Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2013

Sep 13, 2013

31971_dirs_2013-09-13_fa7ecd96-b914-4c01-9605-275e6bf68b44.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2013-09-11

Reporting Person: ABRAHAM WILLIAM (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-09-11 Common Stock M 2577 $25.03 Acquired 21659 Direct
2013-09-11 Common Stock M 7423 $25.03 Acquired 29082 Direct
2013-09-11 Common Stock S 7423 $33.4809 Disposed 21659 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-09-11 Options To Purchase Common Stock $25.03 M 2577 Disposed 2014-05-18 Common Stock (2577) Direct
2013-09-11 Options To Purchase Common Stock $25.03 M 7423 Disposed 2014-05-18 Common Stock (7423) Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.45 to $33.52. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.

F2: 5 year vesting schedule, 20% vest each year starting 5/18/2005